INTELLECT NEUROSCIENCES INC has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOMARCK PHARMACEUTICALS LTD, BIOTECON THERAPEUTICS GMBH and MALLUCCI LIVIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Israel | 2 | |
#7 | China | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Heterocyclic compounds | |
#7 | Analysing materials | |
#8 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Chain Daniel G | 16 |
#2 | Rogers Norman H | 5 |
#3 | Chain Benjamin | 4 |
#4 | Fitzer-Attas Cheryl | 3 |
#5 | Horikoshi Yuko | 1 |
#6 | Maeda Masahiro | 1 |
#7 | Benjamin Chain | 1 |
#8 | Keller Brian C | 1 |
#9 | Rohn Troy T | 1 |
#10 | Kinoshita Noriaki | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020185913A1 | Indole-3-propionic acids and salts and esters thereof for treating skin disorders | |
EP2771030A1 | Compositions and methods for treatment of proteinopathies | |
CA2826286A1 | Treatment of tauopathies | |
WO2008024914A2 | 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom | |
US2008025988A1 | Monoclonal antibodies and use thereof | |
AU2003256578A1 | Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease | |
AU2002367734A1 | SPECIFIC ANTIBODIES TO AMYLOID Beta PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | |
CN101935352A | As immunogenic chimeric peptide and antibody thereof, and utilize chimeric peptide or antibody to carry out the method for immunity | |
EP1752472A2 | Chimeric amyloid beta peptides |